Literature DB >> 6170515

Platelet function in diabetes mellitus in relationship to complications, glycosylated haemoglobin and serum lipoproteins.

D J Betteridge, J Zahavi, N A Jones, B Shine, V V Kakkar, D J Galton.   

Abstract

Mean levels of beta-thromboglobulin and platelet factor 4 were highly significantly elevated in diabetes compared to controls (72.6 v. 36.3 ng/ml, P less than 0.0005; 48.5 v. 16.5 ng/ml, P less than 0.0005; respectively) as was malondialdehyde formation (12.4 v. 8.1 nmol/10(9) platelets, P less than 0.0005). Diabetes with retinopathy had significantly higher levels of beta-thromboglobulin than those without retinopathy (79 v. 70 ng/ml; P less than 0.042). However, those diabetics without clinical evidence of vascular disease had levels of beta-thromboglobulin and platelet factor 4 significantly higher than controls. beta-Thromboglobulin did not correlate with glycosylated haemoglobin but did correlate significantly with individual lipid and lipoprotein levels (beta-thromboglobulin v. total triglyceride, P less than 0.029; v. VLDL triglyceride, P less than 0.041; v. LDL cholesterol, P less than 0.042; v. HDL/total cholesterol ratio, P less than 0.02). Abnormal platelet function may contribute to the vascular complications of diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170515     DOI: 10.1111/j.1365-2362.1981.tb02116.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  8 in total

1.  Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction.

Authors:  G A Oswald; C C Smith; A P Delamothe; D J Betteridge; J S Yudkin
Journal:  Br Heart J       Date:  1988-06

2.  Beta-thromboglobulin and fibrinopeptide A in diabetes mellitus as markers of vascular damage.

Authors:  M C Librenti; A D'Angelo; P Micossi; B Garimberti; P M Mannucci; G Pozza
Journal:  Acta Diabetol Lat       Date:  1985 Jan-Mar

3.  A study of platelet-relevant parameters in patients with diabetic microangiopathy.

Authors:  M Porta; A M Peters; S A Cousins; E Cagliero; M L FitzPatrick; E M Kohner
Journal:  Diabetologia       Date:  1983-07       Impact factor: 10.122

4.  Increased arachidonic acid incorporation into platelet phospholipids in type 2 (non-insulin-dependent) diabetes.

Authors:  D P Mikhailidis; J Y Jeremy; M A Barradas; P Dandona
Journal:  Diabetologia       Date:  1984-08       Impact factor: 10.122

5.  Increased platelet thromboxane receptor sensitivity in diabetic patients with proliferative retinopathy.

Authors:  A Collier; P Tymkewycz; R Armstrong; R J Young; R L Jones; B F Clarke
Journal:  Diabetologia       Date:  1986-08       Impact factor: 10.122

6.  Increased platelet volume--sign of impaired thrombopoiesis in diabetes mellitus.

Authors:  D Tschöpe; E Langer; S Schauseil; P Rösen; L Kaufmann; F A Gries
Journal:  Klin Wochenschr       Date:  1989-02-15

7.  beta-thromboglobulin and platelet factor 4 levels in retinal vein occlusion.

Authors:  P M Dodson; J Westwick; G Marks; V V Kakkar; D J Galton
Journal:  Br J Ophthalmol       Date:  1983-03       Impact factor: 4.638

8.  Platelet and coagulation factors in proliferative diabetic retinopathy.

Authors:  D Q Borsey; C V Prowse; R S Gray; J Dawes; K James; R A Elton; B F Clarke
Journal:  J Clin Pathol       Date:  1984-06       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.